Thommessen has advised EXACT Therapeutics AS in its NOK 155 million private placement of new and existing shares and listing on Merkur Market.
EXACT Therapeutics (previously named Phoenix Solutions) is a clinical stage Norwegian biotech company spun out of GE Healthcare in 2012, currently developing a technology platform for targeted drug delivery – Acoustic Cluster Therapy (ACT®). ACT® is a unique approach to ultrasound-mediated, targeted drug delivery – capable of enhancing significantly the clinical utility of a wide range of therapeutic molecules and nano-drugs across a multitude of indications.
The private placement was directed towards a selected group of high quality investors and existing shareholders. Carnegie AS acted as financial advisor.
The Thommessen deal team comprised Christian G. Sagstad (Partner, M&A and ECM), Lars Martin Sveen (Managing Associate, M&A and ECM) and Emil Dragvold (Associate, M&A and ECM).